Psoriatic arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 16, Issue 4, 2002, Pages 523-535

  Veale, Douglas ^b   FitzGerald, Oliver ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Angiogenesis; Genetics; Peripheral arthritis; Psoriasis; Psoriatic arthritis; Spondylitis; Spondyloarthropath ies; T cells

Indexed keywords

ANGIOPOIETIN; ANTIGEN; ANTINEOPLASTIC AGENT; AUTOANTIGEN; CYCLOSPORIN; HLA C ANTIGEN; HLA DR7 ANTIGEN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN; METHOTREXATE; NEUROPEPTIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; RETINOID; SALAZOSULFAPYRIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VITAMIN D DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; T LYMPHOCYTE RECEPTOR;

ANGIOGENESIS; ARTHRITIS; ARTHROPATHY; BACTERIAL INFECTION; CELL PROLIFERATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; GENETICS; HEREDITY; HUMAN; IMMUNE RESPONSE; INJURY; MORPHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; PSYCHOTRAUMA; REVIEW; RHEUMATOID ARTHRITIS; SKIN DISEASE; SPONDYLITIS; SPONDYLOARTHROPATHY; SYNOVITIS; SYNOVIUM; T LYMPHOCYTE; VASCULAR DISEASE; VIRUS INFECTION; PATHOPHYSIOLOGY; CELL MIGRATION; DISEASE COURSE; DISEASE EXACERBATION; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; PHENOTYPE; PSORIASIS; SAPHO SYNDROME; VASCULAR ENDOTHELIUM;

ARTHRITIS, PSORIATIC; HUMANS;

EID: 0036726506     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6942(02)90248-2     Document Type: Review

References (67)

1. Scarpa R, Oriente P, Pucino A et al. Psoriatic arthritis in psoriatic patients. British Journal of Rheumatology 1984; 23(4): 246-250.
2. Jones SM, Armas JB, Cohen MG et al. Psoriatic arthritis: Outcome of disease subsets and relationship of joint disease to nail and skin disease. British Journal of Rheumatology 1994; 33(9): 834-839.
3. Gladman DD, Anhorn KA, Schachter RK et al. HLA antigens in psoriatic arthritis. Journal of Rheumatology 1986; 13(3): 586-592.
4. Wright V, Roberts MC & Hill AG. Dermatological manifestations in psoriatic arthritis: A follow-up study. Acta Dermato-Venereologica 1979, 59(3): 235-240.
5. Mulherin D, Bresnihan B & FitzGerald O. Digital denervation associated with absence of nail and distal interphalangeal joint involvement in psoriatic arthritis. Journal of Rheumatology 1995; 22(6): 1211-1212.
6. McGonagle D, Conaghan PG & Emery P. Psoriatic arthritis: A unified concept twenty years on. Arthritis & Rheumatism 1999; 42(6): 1080-1086.
7. Veale D, Rogers S & Fitzgerald O. Classification of clinical subsets in psoriatic arthritis. British Journal of Rheumatology 1994; 33(2): 133-138.
8. Gladman DD, Shuckett R, Russell ML et al. Psoriatic arthritis (PSA) - An analysis of 220 patients. Quarterly Journal of Medicine 1987; 62(238): 127-141.
9. McInnes IB, Illei GG, Danning CL et al. IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. Journal of Immunology 2001; 167(7): 4075-4082.
10. Gladman DD. Natural history of psoriatic arthritis. Baillières Clinical Rheumatology 1994; 8(2): 379-394.
11. Schmitt-Egenolf ME, Eiermann TH, Boehncke WH et al. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: A population- and family-based study. Journal of Investigative Dermatology 1996; 106(4): 711-714.
12. Trembath RC, Clough RL, Rosbotham JL et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Human Molecular Genetics 1997; 6(5): 813-820.
13. Nair RP, Stuart P, Henseler T et al. Localization of psoriasis-susceptibility locus PSORSI to a 60-kb interval telomeric to HLA-C. American Journal of Human Genetics 2000; 66(6): 1833-1844.
14. Gonzalez S, Martinez-Borra J, Del Rio J et al. The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. Journal of Investigative Dermatology 2000; 115(5): 824-828.
15. Asumalahti K, Laitinen T, Itkonen-Vatjus R et al. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Human Molecular Genetics 2000; 9(10): 1533-1542.
16. Al-Heresh A, Cox BM, Dixey J et al. TNFα-308 and -238 polymorphisms in psoriatic arthritis and the association with HLA-DRB1 genotypes. Arthritis & Rheumatism 1997; 40(supplement no. 9): S568.
17. Hohler T, Kruger A, Schneider PM et al. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. Journal of Investigative Dermatology 1997; 109(4): 562-565.
18. Kaluza WR, Reuss E, Grossmann S et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. Journal of Investigative Dermatology 2000; 114(6): 1180-1183.
19. Matthews D, Fry L, Powels A et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nature Genetics 1996; 14(2): 231-233.
20. Tomfohrde J, Silverman A, Barnes R et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994; 264(5162): 1141-1145.
21. Burden A, Javed S, Bailey M et al. Genetics of psoriasis: Paternal inheritance and a locus on chromosome 6p. Journal of Investigative Dermatology 1998; 110(6): 958-960.
22. Gonzalez S, Martinez-Borra C, Torre-Alonso J et al. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis & Rheumatism 1999; 42(5): 1010-1016.
23. Gonzalez SB, Martinez-Borra C, Lopez-Vazquez J et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic in the Jewish population. Human Immunology 2001; 62(6): 632-638.
24. Vasey FB, Deitz C, Fenske NA et al. Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. Journal of Rheumatology 1982; 9(5):719-722.
25. Ishihara KA, Kosugi T, Kato M et al. Relationships between the onset of pustulosis palmaris et plantaris, periodontitis and bacterial heat shock proteins. Oral Microbiology and Immunology 2001; 15(4): 232-237.
26. Gerard HW, Wang Z, El-Gabalawy GF et al. Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis & Rheumatism 2001; 44(7): 1689-1697.
27. Kempsell KC, McColm CJ, Bagshaw AA et al. Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: Prevalence in diseased synovial tissue suggests lack of specific association with rheumatoid arthritis. Infection and Immunity 2001; 69(3): 1821-1831.
28. Winchester R, Brancato L, Itescu S et al. Implications from the occurrence of Reiter's syndrome and related disorders in association with advanced HIV infection. Scandinavian Journal of Rheumatology 1988; 74 (supplement): 89-93.
29. Espinoza LB, Vasey A, Cahalin FB et al. Psoriatic arthritis and acquired immunodeficiency syndrome. Arthritis & Rheumatism 1988; 31: 1034-1040.
30. Njobvu PM & McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. Journal of Rheumatology 2000; 27: 1699-1702.
31. Taglione EV, Martini ML, Galluzzo P et al. Hepatitis C virus infection: Prevalence in psoriasis and psoriatic arthritis. Journal of Rheumatology 1999; 26(2): 370-372.
32. Kirby BA-J, Cooper O, Corbitt RJ et al. Investigation of cytomegalovirus and human herpes viruses 6 and 7 as possible causative antigens in psoriasis. Acta Dermato-Venereologica 2000; 80(6): 404-406.
33. Eedy DJ, Johnston CF, Shaw C et al. Neuropeptides in psoriasis: An immunohistochemical and radioimmunoassay study. Journal of Investigative Dermatology 1991; 96: 434-438.
34. Langevitz P, Baskila D, Gladman DD. Arthritis precipitated by physical trauma. Journal of Rheumatology 1990; 17: 695-697.
35. Sandorfi N & Freundlich B. Psoriatic and seronegative inflammatory arthropathy associated with a traumatic onset: 4 cases and a review of the literature. Journal of Rheumatology 1997; 24(1): 187-192.
36. Punzi L, Pianon M, Bertazzolo N et al. Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: A study of 25 patients. Clinical and Experimental Rheumatology 1998; 16(3): 277-281.
37. Veale DJ, Farrell M & Fitzgerald O. Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia. British Journal of Rheumatology 1993; 32(5): 413-416.
38. Fearon U & Veale DJ. Pathogenesis of psoriatic arthritis. Clinical Experimental Dermatology 2001; 26: 333-337.
39. Wittkowker E. Psychological aspects of psoriasis. Lancet 1946; 41: 566-569.
40. Fortune DG, Main CJ, O'Sullivan TM et al. Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress. British Journal of Dermatology 1997; 137(5): 755-760.
41. Chikanza IC & Grossman AB. Hypothalamic-pituitary-mediated immunomodulation: Arginine vasopressin is a neuroendocrine immune mediator. British Journal of Rheumatology 1998; 37: 131-136.
42. + lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nature Medicine 1999; 5: 1178-1182.
43. Laloux L, Voisin MC, Allain J et al. Immunohistological study of enthesis in spondyloarthropathies: Comparison in rheumatoid arthritis and osteoarthritis. Annals of the Rheumatic Diseases 2001; 60(4): 316-321.
44. Veale DJ, Yanni G, Rogers S et al. Reduced synovial membrane ELAM-1 expression, macrophage numbers and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis & Rheumatism 1993; 36: 893-900.
45. + T lymphocytes in psoriatic arthritis. Journal of Rheumatology 1999; 26(5): 1117-1124.
46. + macrophages into the epidermis. Archives of Dermatology Research 1992; 284: 375-379.
47. Gottlieb SL, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Medicine 1995; 1: 442-447.
48. Costello PJ, Winchester RJ, Curran SA et al. Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions that appear antigen driven. Journal of Immunology 2001; 166(4): 2878-2886.
49. + T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proceedings of the National Academy of Sciences USA 1994; 91(20): 9282-9286.
50. Tassiulas I, Duncan SR, Centola M et al. Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Human Immunology 1999; 60(6): 479-491.
51. + T-helper and a T-killer cell. Nature 1998; 393(6684): 474-478.
52. Nicholoff BJ, Bonish B, Huang BB et al. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. Journal of Dermatological Science 2000; 24(3): 212-225.
53. Austin LM, Ozawa M, Kikuchi T et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type I cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. Journal of Investigative Dermatology 1999; 113(5): 752-759.
54. Ritchlin C, Haas-Smith SA, Hicks D et al. Patterns of cytokine production in psoriatic synovium. Journal of Rheumatology 1998; 25(8): 1544-1552.
55. Danning CL, Illei GG, Hitchon C et al. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis & Rheumatism 2000; 43(6): 1244-1256.
56. Pitzalis C Cauli A, Pipitone N et al. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis & Rheumatism 1996; 39(1): 137-145.
57. Braverman IM & Yen A. Microcirculation in psoriatic skin. Journal of Investigative Dermatology 1974; 62: 493-502.
58. Braverman IM & Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. Journal of Investigative Dermatology 1977; 68: 53-60.
59. Zaric D, Worm AM, Stahl D et al. Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scandinavian Journal of Rheumatology 1981; 10(3): 249-252.
60. Bhushnan MM, Herrick AL & Griffiths CE. Nailfold video capillaroscopy in psoriasis. British Journal of Dermatology 2000; 142(6): 1171-1176.
61. Hull SM, Goodfield M, Wood EJ et al. Active and inactive edges of psoriatic plaques: Identification by tracing and investigation by laser-Doppler flowmetry and immunocytochemical techniques. Journal of Investigative Dermatology 1989; 92: 782-785.
62. Reece R, Canete J, Parsons W et al. Distinct vascular patterns in the synovitis of psoriatic, reactive and rheumatoid arthritis. Arthritis & Rheumatism 1999; 142: 1481-1485.
63. Asahara T, Chen D, Tomono T et al. Tie 2 receptor ligands, Angiopoietin 1 and angiopoietin 2, modulate VEGF-Induced postnatal neovascularisation. Circulation Research 1998; 83: 342-343.
64. Peters K. Vascular endothelial growth factor and the angiopoietins. Working together to build a better blood vessel. Circulation Research 1998; 83: 342-343.
65. Creamer D, Jaegger R, Allen M et al. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. British Journal of Dermatology 1997; 137: 851-855.
66. Fearon U, Reece RJ, Blythe D et al. Synovial cytokine and growth factor regulation of MMPs/TIMPs: Implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Annals of the New York Academy of Sciences 1999; 878: 619-621.
67. Kuroda KS, Sapadin A, Shoji T et al. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. Journal of Investigative Dermatology 2001; 116(5): 713-720.